Arctic Microbes Yield Promising Antibiotic Candidates

Researchers discover compounds that inhibit harmful bacteria without promoting resistance.

Scientists identified two compounds from Arctic actinobacteria with strong antibacterial properties.
The compounds target enteropathogenic E. coli (EPEC), which causes severe diarrhea in children.
One compound inhibits EPEC virulence without affecting bacterial growth, reducing resistance risk.
The research highlights the untapped potential of marine actinobacteria for new antibiotic development.
Further studies are needed to optimize compound production and investigate clinical applications.